Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials

Published:2024-07 Issue: Volume: Page:
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Spratt Daniel E.,Liu Vinnie Y.T.,Jia Angela Y.,Royce Trevor J.,Sandler Howard M.,Pugh Stephanie L.,Tran Phuoc T.,Feng Felix Y.

Publisher

Elsevier BV

Reference5 articles.

1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Prostate cancer v4.2023.

2. Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the International Staging Collaboration for Cancer of the Prostate;Dess;JAMA Oncol,2020

3. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials;Esteva;NPJ Digit Med,2022

4. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement;Collins;Circulation,2015

5. Evaluation of new tests and interventions for prostate cancer management: a systematic review;Olleik;J Natl Compr Cancer Netw,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP